Incidence, risk, and evolution of osteoporotic hip fractures in Spanish women using a Markov type model;Incidencia, riesgo y evolución de las fracturas osteoporóticas de cuello de fémur en las mujeres en España, a partir de un modelo de Markov

Medicina Clinica

Volumn 114, Issue SUPPL. 2, 2000, Pages 63-67

  Cabasés Hita, Juan M ^a   López, Guadalupe Carmona ^b   Vecino, Ramón Hernández ^c  

^a PUBLIC UNIVERSITY OF NAVARRE   (Spain)

^b ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^c Medical affairs Merck sharp and Dohme ltd   (Spain)

Author keywords

Costs; Hip fracture; Incidence; Markov models; Osteoporosis

Indexed keywords

AGED; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; FEMUR NECK FRACTURE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; OSTEOPOROSIS; PROBABILITY; PROSPECTIVE STUDY; RISK FACTOR; SPAIN;

AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; FEMALE; FEMORAL NECK FRACTURES; HUMANS; INCIDENCE; MALE; MARKOV CHAINS; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 0033656877     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Consensus Development Conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993; 94: 646-650.
2. Gallagher JC, Melton LJ, Riggs BL, Bergstrach E. Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Rel Res 1980; 150: 163-171.
3. Lizaur A, Puchades A, Sánchez F, Anta J, Gutiérrez P. Epidemiology of trochanteric fractures of the femur in Alicante, Spain, 1974-1982. Clin Orthop 1987; 218: 24-31.
4. Kanis JA. Epidemiología de la fractura de cadera en Europa: el estudio MEDOS. Rev Clin Esp 1991; 188: 16-19.
5. Fernández L, Hernández J, González-Orus A, De No Estella L, Martín F. Epidemiologia de las fracturas de la extremidad proximal del fémur en la provincia de Salamanca. Rev Ortop Traum 1992; 36IB: 329-333.
6. Olmos JM, Martínez J, García J, Matorras P, Moreno JJ, González-Macías J. Incidencia de fractura de cadera en Cantabria. Med Clin (Barc) 1992; 99: 729-731.
7. Altadill A, Gómez C, Virgós MJ, Díaz B, Cannata JB. Epidemiología de la fractura de cadera en Asturias. Med Clin (Barc) 1995; 105: 281-286.
8. Sosa M, Segarra MC, Limiñana JM, Hernández D, González A, Betancor P. Morbilidad y mortalidad de la fractura osteoporótica de la extremidad proximal del fémur tras un año de seguimiento. Med Clin (Barc) 1993; 101: 481-483.
9. Knobel H, Díez A, Arnau D, Alier A, Ibáñez J, Campodarve Y et al. Secuelas de la fractura osteoporótica de fémur en Barcelona. Med Clin (Barc) 1992; 98: 453-455.
10. Tosteson A. Cost- effectiveness evaluation of Fosamax for the Province of Ontario (Canada). Mimeo, 1996.
11. Chrischilles EA, Butler CD, Davis CS, Wallace RB. A model of lifetime osteoporosis impact. Arch Intern Med 1991; 151: 2026-2032.
12. Chrischilles E, Shireman T, Wallace R. Costs and health effects of osteoporosis fractures. Bone 1994; 15: 377-386.
13. Phillips S, Fox N, Jacobs J, Wright WE. The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone 1988; 9: 271-279.
14. Lane A. Direct costs of osteoporosis for New Zealand women. Pharmaco- Economics 1996; 9: 231-245.
15. Cummings SR, Black DM, Rubin SM. Lifetime risks of hip, Colles or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med 1989; 149: 2445-2448.
16. Manton KG. A longitudinal study of functional change and mortality in the United States. J Gerontol 1988; 43: S153-S161.
17. Sosa M. La fractura osteoporótica de cadera en España. Rev Esp Enf Metab Oseas 1993; 2: 189-192.
18. Melton LJ, Thamer M, Ray NF, Chan JK, Chestnut III CH, Einhorn TA et al. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 1997; 12: 16-23.